Panelists discuss how the management of uncomplicated urinary tract infections (UTIs) is evolving, with promising new ...

Experts at the Community Oncology Conference discuss innovative patient navigation programs, emphasizing technology's role ...

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Lalan Wilfong, MD, of Thyme Care and Texas Oncology, discusses a session on circulating tumor DNA (ctDNA) and shares insight ...

Kate Baker, MD, MMHC, medical director of value-based care at Tennessee Oncology, talks about innovations in cancer care ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Kimlin Tam Ashing, PhD, explores how strengthening community engagement can enhance cancer research and inform more effective policy development.

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

The results offer some of the first glimpses into real-world findings of the Janus kinase inhibitor in patients with ...

Duke Appiah, PhD, MPH, is an associate professor at the Texas Tech University Health Sciences Center. Duke Appiah, PhD, MPH, ...

Duke Appiah, PhD, MPH, explores racial disparities in maternal health outcomes for pregnant women with cancer, revealing ...

Because clinical trials do not mimic the real-world application of multiple myeloma treatments, Ajai Chari, MD, discussed the variety of patient factors clinicians should consider in their practice.